Biopolym. Cell. 2012; 28(4):322-325.
Short Communications
The level of blood plasma mitochondrial DNA upon acute myocardium damage in experiment
1, 3Sudakov N. P., 3Popkova T. P., 1Novikova M. A., 2Katyshev A. I., 1Nikiforov S. B., 1Pushkarev B. G., 1Goldberg O. A., 4, 6Klimenkov I. B., 1Lepekhova S. A., 3Ezhikeeva S. D., 3Ten M. N., 5Osipov V. G., 2, 6Konstantinov Yu. M.
  1. Scientific Center for Reconstructive and Restorative Surgery, Siberian Branch, Russian Academy of Medical Sciences
    1, Bortsov Revolyutsii Str., Irkutsk, Russian Federation, 664003
  2. Siberian Institute of Plant Physiology and Biochemistry, Siberian Branch of the Russian Academy of Sciences
    132, Lermontova Str., Irkutsk, Russian Federation, 664033
  3. Regional Clinical Hospital
    100, m-n Yubileinyi, Irkutsk, Russian Federation, 66409
  4. Limnological Institute, Siberian Branch of the Russian Academy of Sciences
    3, Ulan-Batorskaya Str., Irkutsk, Russian Federation, 665033
  5. Territorial Center of Catastrophe Medicine
    100 k3, m-n Yubileinyi, Irkutsk, Russian Federation, 664049
  6. Irkutsk State University
    1, Karl Marks Str., Irkutsk, Russian Federation, 664003


The aim of the present investigation is to study the level of plasma mtDNA as a potential marker of cardiomyocyte damage in 2 and 4 h after subcutaneous injection of adrenaline and during the formed morphological alterations of the myocardium (3 days). Methods. Real time PCR. Male Wistar rats were used as the experimental animals. Results. It was shown that during the increase in the activity of cytolysis biomarkers, at the first hours after adrenaline injection, no reliable increase is observed in the level of free circulating blood mtDNA. A tendency of 2.5-fold increase in this parameter was established at the third day after adrenaline injection during the development of acute inflammatory process in the myocardium. On the whole, further researches are needed on the dynamics of mtDNA level upon acute damage of the myocardium in experimental and clinical investigations for unbiased estimation of the prospects of using the parameter in laboratory diagnostics.
Keywords: mitochondrial DNA, cardiovascular diseases, adrenaline myocarditis, cytolysis biomarkers


[1] Searle J., Danne O., Muller C., Mockel M. Biomarkers in acute coronary syndrome and percutaneous coronary intervention Minerva Cardioangiol 2011 59, N 3:203–223.
[2] Ricci F., De Caterina R. Isolated creatine kinase-MB rise with normal cardiac troponins: a strange occurrence with difficult interpretation J. Cardiovasc. Med. (Hagerstown) 2011 12, N 10:736–740.
[3] Chiu R. W., Chan L. Y., Lam N. Y., Tsui N. B., Ng E. K., Rainer T. H., Lo Y. M. Quantitative analysis of circulating mitochondrial DNA in plasma Clin. Chem 2003 49, N 5:719–726.
[4] Ellinger J., Muller S. C., Wernert N., von Ruecker A., Bastian P. J. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy BJU Int 2008 102, N 5:628–632.
[5] Zachariah R. R., Schmid S., Buerki N., Radpour R., Holzgreve W., Zhong X. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors Obstet. Gynecol 2008 112, N 4:843–850.
[6] Nepomnyashchikh L. M. Alternative insufficiency of muscle cells of the heart upon metabolic and ischemic damage Moscow: RAMS publishing house, 1998 111 p.
[7] Yousefi S., Mihalache C., Kozlowski E., Schmid I., Simon H. U. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps Cell Death Differ 2009 16, N 11:1438–1444.